(UPDATE) Ixazomib
(UPDATE) Daratumumab (MM)
Selinexor
Elotuzumab
ASCO: COVID-19 Medical Resources
NCCN Guidelines for Patients: Multiple Myeloma
NCCN-Funded Clinical Trials: Find a Clinical Trial
ASH: COVID-19 Resources for Managing Blood Cancers